Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 351–400 of 18616
On June 22, 2026, Johnson Outdoors Inc. (the “ Company ”) announced that it has appointed Asad Rahman as Vice President and Chief Financial Officer of the Company effective as of June 30, 2026.
Mr. Johnson will step down from those roles effective as of June 30, 2026.
appointed Axel André as Chief Financial Officer of the Company, effective July 27, 2026
Effective June 17, 2026, the board of directors (the “Board”) of the Company appointed John Fraser, the Company’s current Chairman of the Board, to serve as its Interim Chief Executive Officer while a search of internal and external candidates is conducted.
On June 17, 2026, Michael Buhle ceased serving as Chief Executive Officer of Aspira Women's Health Inc. (the "Company").
On June 15, 2026, Axel André, Executive Vice President and Chief Financial Officer of Reinsurance Group of America, Incorporated (the “Company”), informed the Company of his resignation from the Company effective July 17, 2026.
Effective June 22, 2026, Laura Cockill, Executive Vice President, Chief Strategy Officer, will assume the role of Executive Vice President and Chief Financial Officer.
Effective June 22, 2026, t he Board of Directors (the “Board”) of Rayonier Advanced Materials Inc. (“RYAM” or the “Company”) appointed Daniel M. Krawczyk as Chief Executive Officer and President of the Company.
Effective June 15, 2026, Blair Aiken is elected by the Board of Directors to serve as President and interim CEO of Panamera Holdings Corporation (collectively, the “Company”).
On June 18, 2026, the board of directors (the “Board”) of the Company appointed Robert Weinstein to the positions of Chief Accounting Officer, Principal Financial Officer and Principal Accounting Officer of the Company, effective immediately.
On June 18, 2026, Petros Pharmaceuticals, Inc. (the “Company”) and Mitchell Arnold, who served as the Company’s Vice President of Finance, Principal Accounting Officer and Principal Financial Officer, mutually agreed to the separation of Mr. Arnold from such roles, effective as of June 18, 2026
Vishwas Setia was separated as the Chief Financial Officer of MapLight Therapeutics, Inc. (the “Company”), effective immediately, following a review of a human resources violation.
the board of directors of the Company appointed Jonathan Gillis, the Company’s Chief Administrative and Accounting Officer, as the Company’s interim Chief Financial Officer and interim principal financial officer, effective June 18, 2026.
On June 15, 2026, Mondelēz International, Inc. (the “Company”) announced the appointment of Amit Banati as Executive Vice President and Chief Financial Officer, effective July 1, 2026 (the “Start Date”).
until Shimon Steinmetz commences his employment as the Company's Chief Financial Officer on or around July 27, 2026, as previously disclosed.
On June 16, 2026, the Company’s Board of Directors appointed Peter Hansen-Chambers as its new Chief Financial Officer
Effective June 18, 2026, Eric Greenhaus resigned as Chief Financial Officer, principal financial officer and principal accounting officer of the Company.
Effective June 18, 2026, Robert Rivas Collins resigned as Chief Executive Officer and principal executive officer of the Company.
Effective June 18, 2026, the Board appointed Chinh Chu, the current President of the Company, as the principal executive officer of the Company.
approved the election of Matthew Domeyer to the position of Chief Financial Officer of the Company, to be effective on July 20, 2026
On June 17, 2026, the Company’s Board of Directors appointed Richard Kaiser as the Company’s interim Chief Executive Officer.
On June 17, 2026, the Company’s Board of Directors received resignation letters from Mr. Steven Gagnon and Mr. John LaViolette as BioForce Nanosciences Holdings, Inc.’s Co-Chief Executive Officers (CEOs), and from Sasha Shapiro the Company’s Vice-President.
On June 17, 2026, the Company’s Board of Directors received resignation letters from Mr. Steven Gagnon and Mr. John LaViolette as BioForce Nanosciences Holdings, Inc.’s Co-Chief Executive Officers (CEOs), and from Sasha Shapiro the Company’s Vice-President.
the Company announced that Cecile Guegan, the Company’s Senior Vice President, Finance, Global Biopharmaceutical Business, will serve as Interim Chief Financial Officer, effective August 16, 2026
Dave Denton notified Pfizer Inc. (the “Company”) that he will step down from his current position as Chief Financial Officer effective August 15, 2026
Effective as of June 30, 2026, the Board appointed Michael McCormick as the Company’s Chief Executive Officer and President and member of the Company’s board of directors.
On June 16, 2026, Nuwellis, Inc. (the “Company” ) announced that John L. Erb resigned from the Company, effective June 30, 2026 (“ Resignation Date ”).
On June 15, 2026, concurrent with Mr. Koscal's succession to the Chief Executive Officer role, David Grizzle, the Company's former Chief Executive Officer for a transitional period that commenced on July 1, 2025, resumed his position as non-executive Chairman of the Board
increased the size of the Board to seven and appointed Matthew J. Koscal as a director, effective June 15, 2026, to serve until the Company's 2027 Annual Meeting of Stockholders, and until the election and qualification of his successor, or earlier death, resignation, retirement, disqualification or removal.
promoted Matthew J. Koscal to the role of President and Chief Executive Officer (principal executive officer), effective as of June 15, 2026
On June 17, 2026, CONMED Corporation (the “Company”) announced that John E. Gallagher has been appointed to serve as the Company’s Executive Vice President, Chief Financial Officer beginning July 15, 2026 (the “Effective Date”).
the board of directors of the Company appointed Mr. Cory T. Newsom to serve as the Chief Executive Officer of the Company, effective upon Mr. Griffith’s retirement on December 31, 2026.
Mr. Griffith’s retirement as Chief Executive Officer will be effective as of December 31, 2026.
On June 17, 2026, the Company also announced the appointment of its new Executive Vice President, Chief Financial Officer and Principal Financial Officer, Mr. Jayant Chauhan, effective as of July 6, 2026.
On June 11, 2026, John E. Gallagher III, Senior Vice President and Chief Financial Officer of Certara, Inc. (the “Company”), tendered his notice of resignation to the Company to pursue another opportunity.
On June 17, 2026, the Company appointed Faiz Mohammed as its Interim Chief Financial Officer and as both principal financial officer and principal accounting officer of the Company for purposes of the Securities Exchange Act of 1934, as amended, effective as of the Effective Date and until a successor may be appointed.
the following individuals were appointed to serve as executive officers of Pubco: Name Position Gerald Bartholomew Smith Chief Executive Officer and President
Sean Ostrower Chief Financial Officer
On June 12, 2026, Karen Hawkins notified Optex Systems Holdings, Inc. (the “Company”) that she intends to resign, effective upon the expiration of her current employment agreement on December 31, 2026
On June 12, 2026, in connection with his appointment as Interim Chief Executive Officer, Mr. Peterson and BioTE entered into an amended and restated employment agreement
On June 16, 2026, the Board of Directors (the “Board”) of AMC Global Media Inc. (the “Company”) appointed Hozefa Lokhandwala, age 51, as Executive Vice President and Chief Financial Officer of the Company, effective as of June 16, 2026.
On June 12, 2026, the Board of Directors of the Company (the “ Board ”) approved the appointment of Nadia Carlsten to serve as President, Chief Executive Officer, Secretary and a director of the Company, effective June 18, 2026 (the “ Effective Date ”).
In addition to serving as the Company’s principal executive officer, Mr. Fregenal was serving as the Company’s principal financial officer and principal accounting officer prior to his termination.
On June 16, 2026, the Board appointed Daniel Weinmann, age 41, to serve as Chief Financial Officer, effectively immediately.
On June 16, 2026, the Board terminated Marco Fregenal as the Company’s Chief Executive Officer, and Mr. Fregenal resigned from his role as a director of the Company, effective immediately.
On June 16, 2026, the Board appointed Adam Rothstein, age 54, to serve as Interim Chief Executive Officer, effective immediately.
Jung Jae Lim, who has served as Co-Chief Executive Officer of the Company since March 2026, has assumed full responsibilities as Chief Executive Officer.
On June 15, 2026, the Board appointed Mr. Lim to serve as interim Chief Financial Officer and Principal Accounting Officer of the Company.
On June 4, 2026, Jay Kim notified the Board of his resignation as Co-Chief Executive Officer, Chief Financial Officer, Director, and from all other positions, offices, directorships, committee memberships, and responsibilities that he holds in the Company and each of its subsidiaries and affiliates.
Pascal Desroches announced his retirement as Senior Executive Vice President and Chief Financial Officer of AT&T Inc. (the “Company”), which will be effective as of December 31, 2026.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.